Trial Profile
Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary) ; Beta-adrenergic receptor antagonists; Calcium channel antagonists; Organic nitrates
- Indications Angina pectoris
- Focus Adverse reactions; Therapeutic Use
- Sponsors Gilead Sciences
- 22 Sep 2015 New trial record
- 14 Aug 2015 Results published in the American Journal of Cardiology.